SRDX - Surmodics EPS beats by $0.15 beats on revenue April, 29 2020 04:15 PM Surmodics Inc. Surmodics (NASDAQ:SRDX): Q2 Non-GAAP EPS of $0.04 beats by $0.15; GAAP EPS of $0.11 beats by $0.28.More news on: Surmodics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...